Biotech Startups

Microbot Medical develops LIBERTY, a single-use, remotely operated endovascular robotic system that lets physicians perform peripheral vascular procedures from a seated position with remote control. The system is aimed at hospitals and interventional physicians seeking to adopt robotic technology for endovascular care.

1 investor

1 investor

MicroIN is a platform that combines cell protection, microencapsulation, and bioinformatics to make sensitive biological inputs (live microorganisms and other bioinputs) more resilient, stable, and scalable. It targets the agro-environmental sector, aiming to improve the shelf life, formulation, and adoption of biology-based agricultural inputs.

1 investor

1 investor

KitoTech Medical develops microMend, a wound closure product combining microstaples with adhesive backing as an alternative to traditional sutures and staples. The company serves both clinical markets through healthcare networks and hospitals, and consumer markets through retail pharmacy chains and online platforms.

1 investor

Microphyt develops microalgae-based ingredients and products for nutrition, dietary supplements, and personal care using proprietary bio-reactor technology. The company serves food, supplement, and cosmetics manufacturers with natural, science-backed ingredients derived from microalgae.

1 investor

Microplate Dx is a diagnostics company developing rapid antimicrobial susceptibility testing technology to identify the correct antibiotic treatment for infections within hours, enabling faster patient treatment and reducing antibiotic resistance. The company targets healthcare providers and focuses on improving clinical outcomes in infectious disease management.

1 investor

Micropoint Technologies is an ISO 13485 certified, cGMP compliant medical device company that develops and manufactures microneedle solutions, including stainless steel, plastic, polymeric, hollow, solid, and custom microneedles. It offers rapid prototyping, product development, and OEM manufacturing, and operates a pilot facility producing clinical batches of dissolving microneedle patches for clinical trials.

1 investor

Micropoint Bio is a microfluidics technology company that develops point-of-care testing (POCT) devices and biochips for clinical diagnostics, including coagulation, cardiac, and infectious disease testing. The company manufactures microfluidic chips and detection instruments for hospitals, laboratories, and clinical settings globally.

1 investor

Microscopy Innovations builds the programmable mPrep ASP automated specimen processors and mPrep specimen and grid capsules for preparing samples and TEM grids for electron microscopy workflows including TEM, vEM, and SEM. Its products serve laboratories doing electron microscopy specimen preparation and immuno-labeling, with capsules that also work with hand-held pipettors.

1 investor

Microvitality develops an ingestible capsule that non-invasively and autonomously collects samples from the small intestine, generating region-specific microbiome data for biomarker discovery, diagnostics, and research. It serves clinicians, researchers, and biotechnology and pharmaceutical companies working on gastrointestinal disease and microbiome science.

1 investor

1 investor

Midwest Bioprocessing Center produces biobased ingredients and compounds from sustainable feedstocks for human health, nutrition, and personal care applications. The company operates through three branded platforms: iActive for cosmetics, zuCarb for pharmaceutical R&D, and bioprocess services.

1 investor

Mighty Therapeutics is a biopharmaceutical company developing mitochondria-targeted medicines to treat mitochondrial dysfunction in rare genetic mitochondrial diseases and common age-related conditions. Its pipeline spans rare genetic diseases, ophthalmic disorders, and neurological conditions, and it delivered the first approved therapy for Barth syndrome.

1 investor

Mii-Bio develops biotech manufacturing technologies that use plant-derived materials and microorganisms, with light-based control mechanisms to enable carbon-neutral chemical production as an alternative to petroleum-based manufacturing.

1 investor

Mikart is a contract development and manufacturing organization (CDMO) that provides pharmaceutical development and manufacturing services across the drug development and commercialization continuum. The company specializes in oral solid and non-sterile oral liquid dosage forms, particularly for pediatric, geriatric, and controlled substance applications.

1 investor

MikrobioMik develops full-spectrum gut microbiota therapies, led by EUTEGRA (MBK-01), a regulatory-authorized treatment for recurrent Clostridioides difficile infection. The company is building a clinical pipeline applying microbial restoration to conditions with limited treatment options, including recurrent acute diverticulitis and decompensated liver cirrhosis.

1 investor

Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.

1 investor

Millennium Health is a healthcare company that provides drug testing and related clinical services. The company operates with a strong focus on compliance and ethical standards across its operations.

1 investor

MIMEDX develops advanced wound care and surgical products derived from placental tissue, serving healthcare professionals and patients. The company provides clinical, scientific, and reimbursement support to help clinicians treat wounds across various clinical settings.

1 investor

Mimetogen is a biotechnology company developing novel therapeutics, with a focus on tavilermide for ophthalmic indications including dry eye disease. The company brings together expertise in drug discovery, development, and clinical research to advance treatment options in ophthalmology.

1 investor

MimiVax is a biopharmaceutical company developing immunotherapies for brain tumors, particularly glioblastoma, by harnessing the immune system to target cancer cells. The company's lead candidate, SurVaxM, is a peptide-based vaccine targeting survivin in cancer cells across multiple indications including glioblastoma, multiple myeloma, and neuroendocrine tumors.

1 investor

Minafin is a chemicals company; no other details are provided on this page.

1 investor

MiNA Therapeutics develops small activating RNA (RNAa) therapeutics, a new class of medicines designed to restore or enhance gene function for treating genetic diseases and other conditions. The company has a platform approach that advances proprietary drug candidates and collaborates with pharmaceutical companies across multiple therapeutic areas.

1 investor